Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count bottle, NDC-68462-878-01; (c) 500-count bottles, NDC-68462-878-05; Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, Inda. Manufactured for: Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430.
Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe…
From the FDA notice · Read the official notice ↗ · All Glenmark recalls
What to do
The agency's notice has the remedy and who to contact.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count bottle, NDC-68462-878-01; (c) 500-count bottles, NDC-68462-878-05; Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, Inda. Manufactured for: Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 11,136 bottles
- Illnesses reported
- None reported
- Manufactured in
- 619 River Dr, Elmwood Park, NJ, United States
- Classification
- Class III
- Recall number
- D-0199-2026
In the FDA's words
- Description
- Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count bottle, NDC-68462-878-01; (c) 500-count bottles, NDC-68462-878-05; Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, Inda. Manufactured for: Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430. Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe Lot #: (a): Lot 17232401, exp 11/2025; Lot 17240974, exp 05/2026 (b): Lot 17232401, exp 11/2025; Lot 17240974, exp 05/2026 (c): Lot 17232401, exp 11/2025; Lot 17240974, exp 05/2026 Distribution: Nationwide in the USA Affected quantity: 11,136 bottles
- Hazard
- Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
More from Glenmark
See all- Glenmark abiraterone acetate tablets recalled for labeling problem
ModerateFDAOct 23, 2026
- Glenmark Clindamycin Phosphate Foam recalled for damaged, leaking containers
ModerateFDAOct 7, 2026